CLOPIXOL A ACTION SEMI-PROLONGEE 50 mg/ml, solution for injection i.m. 5 ampoules of 1 ml
Active ingredients: Zuclopenthixol acetate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 1 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOPIXOL A ACTION SEMI-PROLONGEE 50 mg/ml, solution injectable I.M.
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 5 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- LUNDBECK SAS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 1992
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63744998CIP75562599CIP133400955625995Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZUCLOPENTHIXOL (ACÉTATE DE)solution | 50 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.